Literature DB >> 30723973

Misuse of prescribed opioids in the United States.

Ramin Mojtabai1, Masoumeh Amin-Esmaeili1,2, Eleeka Nejat3, Mark Olfson4.   

Abstract

PURPOSE: To assess the prevalence and correlates of self-reported misuse of prescribed-opioid medications in the US general population.
METHOD: In 31 068 adult participants of the National Survey on Drug Use and Health (NSDUH) 2015 and 2016 who reported using opioids in the past year, we assessed the prevalence and correlates of self-reported misuse of prescribed opioids, defined as using a larger dose, more frequently, or longer than prescribed. Multivariable logistic-regression models and the machine-learning method of boosted regression were used to identify the correlates of misuse.
RESULTS: On the basis of weighted NSDUH estimates, of more than 89 million US adults who used prescription opioids every year, close to 3.9 million (4.4%) reported misused the prescribed medications. Prescribed-opioid misuse was most strongly associated with co-occurring misuse of opioids without a prescription, misuse of benzodiazepines, other drug-use disorders, history of illegal activity, and psychological distress. Misuse of prescribed opioids was also strongly associated with prescription opioid-use disorder, especially among those who misused more potent opioids or started misusing opioids before the current year.
CONCLUSIONS: Misuse of prescribed opioids is associated with other high-risk behaviors and adverse health outcomes. The findings call for better monitoring of opioid prescription in clinical practice.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  drug use disorder; medication misuse; painkillers; pharmacoepidemiology; prescription opioid

Mesh:

Substances:

Year:  2019        PMID: 30723973     DOI: 10.1002/pds.4743

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  An Evaluation of the Effect of the OxyContin Reformulation on Unintentional Fatal and Nonfatal Overdose.

Authors:  Daniel C Beachler; Kelsey Hall; Renu Garg; Geetanjoli Banerjee; Ling Li; Luke Boulanger; Huseyin Yuce; Alexander M Walker
Journal:  Clin J Pain       Date:  2022-06-01       Impact factor: 3.423

2.  Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR.

Authors:  Tessa K Novick; Aditya Surapaneni; Jung-Im Shin; G Caleb Alexander; Lesley A Inker; Eric A Wright; Alex R Chang; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-03       Impact factor: 8.237

3.  Information on doctor and pharmacy shopping for opioids adds little to the identification of presumptive opioid abuse disorders in health insurance claims data.

Authors:  Alexander M Walker; Lisa B Weatherby; M Soledad Cepeda; Daniel C Bradford
Journal:  Subst Abuse Rehabil       Date:  2019-08-01

4.  Provider Perspectives of Battlefield Acupuncture: Advantages, Disadvantages and Its Potential Role in Reducing Opioid Use for Pain.

Authors:  Karleen F Giannitrapani; Princess E Ackland; Jesse Holliday; Steve Zeliadt; Juli Olson; Benjamin Kligler; Stephanie L Taylor
Journal:  Med Care       Date:  2020-09       Impact factor: 3.178

5.  Development of a machine learning algorithm for early detection of opioid use disorder.

Authors:  Zvi Segal; Kira Radinsky; Guy Elad; Gal Marom; Moran Beladev; Maor Lewis; Bar Ehrenberg; Plia Gillis; Liat Korn; Gideon Koren
Journal:  Pharmacol Res Perspect       Date:  2020-12

6.  A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.

Authors:  Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams
Journal:  BMC Public Health       Date:  2020-11-18       Impact factor: 3.295

7.  National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States.

Authors:  Vikram Jairam; Daniel X Yang; Vivek Verma; James B Yu; Henry S Park
Journal:  JAMA Netw Open       Date:  2020-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.